Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Change in Account Payables (2024 - 2025)

Historic Change in Account Payables for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $520709.0.

  • Neuphoria Therapeutics' Change in Account Payables rose 15441.02% to $520709.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $520709.0, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2025, which is 4351.2% up from last year.
  • Latest data reveals that Neuphoria Therapeutics reported Change in Account Payables of $520709.0 as of Q4 2025, which was up 15441.02% from $216359.0 recorded in Q3 2025.
  • In the past 5 years, Neuphoria Therapeutics' Change in Account Payables ranged from a high of $580663.0 in Q2 2025 and a low of -$917668.0 during Q3 2024